Statistics for Tandem Diabetes Care (id:6428 TNDM)
Valuation metrics
Market cap
1.88B
Enterprise value
1.95B
Trailing P/E (ttm)
-8.98
Forward P/E
-23.63
PEG ratio
-23.63
Price/Sales (ttm)
2.20
Price/Book (mrq)
7.90
Enterprise Value/Revenue
2.28
Enterprise Value/EBITDA
-14.93
Overview
Shares outstanding
65.68M
Float
65.11M
Shares short
8.39M
% Held by insiders
0.01%
% Held by institutions
1.14%
Average volume (10 days)
2.21M
Average volume (90 days)
Price summary
52-Week low
18.45
52-Week high
53.69
52-Week change
38.17%
Beta
1.37
50-Day moving average
38.05
200-Day moving average
37.95
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
October 10th, 2017
Ex-dividend date
Last split factor
2:1
Last split date
October 10th, 2017
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-14.84%
Operating margin
-10.70%
Operational effectiveness
Return on assets
-9.69%
Return on equity
-45.96%
Income statement
Revenue (ttm)
13.08
Revenue per share (ttm)
13.08
Quarterly revenue growth (yoy)
Gross profit (ttm)
367.69M
EBITDA
-130,696,896.00
Net income to common (ttm)
-126,782,000.00
Diluted EPS (ttm)
-1.94
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
473.30M
Total cash per share (mrq)
7.21
Total debt (mrq)
475.95M
Total Debt/Equity (mrq)
200.22
Current ratio (mrq)
290.40%
Book value per share (mrq)
3.62
Cash flow
Cash flow statement
6.29M
Levered free cash flow (LFCF)
-14,131,938.00